MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL
- PMID: 9574549
MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL
Abstract
Infection of BALB/c mice with Listeria monocytogenes primes CD8+ cytotoxic T cells specific for four different H2-Kd-restricted peptides. In vitro restimulation of L. monocytogenes immune splenocytes with each of these peptides resulted in larger T cell responses to p60 217-225 and mpl 84-92 than to LLO 91-99 and p60 449-457. Direct frequency analyses of immune splenocytes, however, revealed that LLO 91-99 and p60 217-225 elicit dominant T cell responses, while p60 449-457 and mpl 84-92 elicit minor, subdominant responses. Restimulation of immune splenocytes with a range of peptide concentrations revealed that T cells with dominant specificities respond optimally to low peptide concentrations, while T cells specific for subdominant epitopes expand maximally to high peptide concentrations. This disparity correlates with the stability of H2-Kd/epitope complexes: the two dominant epitopes form stable complexes, while the subdominant epitopes form less stable complexes with H2-Kd. Interestingly, T cells specific for LLO 91-99 and p60 217-225 express more complex TCR-Vbeta repertoires than p60 449-457- and mpl 84-92-specific T cells. Thus, in our system, dominant T cell responses have relatively diverse TCR repertoires and are specific for peptides that form stable complexes with MHC class I molecules. Determining the precise roles of epitope/MHC class I stability and TCR repertoire in the generation of dominant T cell responses will require further investigation.
Similar articles
-
Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua.J Immunol. 1999 Apr 15;162(8):4781-9. J Immunol. 1999. PMID: 10202020
-
Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope.J Immunol. 1994 Jan 15;152(2):686-94. J Immunol. 1994. PMID: 7506732
-
Immunodominant and subdominant CTL responses to Listeria monocytogenes infection.J Immunol. 1997 Apr 1;158(7):3366-71. J Immunol. 1997. PMID: 9120295
-
[MHC tetramers: tracking specific immunity].Acta Med Croatica. 2003;57(4):255-9. Acta Med Croatica. 2003. PMID: 14639858 Review. Croatian.
-
MHC class I restricted T cell responses to Listeria monocytogenes, an intracellular bacterial pathogen.Immunol Res. 1999;19(2-3):211-23. doi: 10.1007/BF02786489. Immunol Res. 1999. PMID: 10493175 Review.
Cited by
-
Immunodomination during peripheral vaccinia virus infection.PLoS Pathog. 2013;9(4):e1003329. doi: 10.1371/journal.ppat.1003329. Epub 2013 Apr 25. PLoS Pathog. 2013. PMID: 23633956 Free PMC article.
-
Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.J Virol. 2002 May;76(9):4251-9. doi: 10.1128/jvi.76.9.4251-4259.2002. J Virol. 2002. PMID: 11932390 Free PMC article.
-
Potentiation of T Cell Stimulatory Activity by Chemical Fixation of a Weak Peptide-MHC Complex.Mol Cells. 2017 Jan;40(1):24-36. doi: 10.14348/molcells.2017.2218. Epub 2017 Jan 31. Mol Cells. 2017. PMID: 28152301 Free PMC article.
-
A modern approach for epitope prediction: identification of foot-and-mouth disease virus peptides binding bovine leukocyte antigen (BoLA) class I molecules.Immunogenetics. 2015 Nov;67(11-12):691-703. doi: 10.1007/s00251-015-0877-7. Immunogenetics. 2015. PMID: 26496773
-
Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines.Hum Vaccin Immunother. 2013 May;9(5):1058-68. doi: 10.4161/hv.23871. Epub 2013 Feb 11. Hum Vaccin Immunother. 2013. PMID: 23399758 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials